Table 3.
Consumption on classes of antibacterial & anti-fungal chemotherapeutic agents
| Class | DDD / 1000 PATIENT-DAYS | ||||
|---|---|---|---|---|---|
| Total | S I | S II | S III | S IV | |
| Cephalosporins | 264.19 | 87.75 | 37.63 | 133.68 | 5.13 |
| I-st generation | 0 | 0 | 0 | 0 | 0 |
| II-nd generation | 46.96 | 27.35 | 4.98 | 14.50 | 0.13 |
| III-rd generation | 198.19 | 57.74 | 31.97 | 103.54 | 4.93 |
| IV-th generation | 13.43 | 1.51 | 0 | 11.92 | 0 |
| V-th generation | 5.60 | 1.15 | 0.67 | 3.72 | 0.06 |
| Carbapenems | 244.59 | 8.16 | 53.84 | 160.36 | 22.23 |
| Glycopeptides | 132.94 | 6.13 | 20.23 | 96.97 | 9.61 |
| Polymyxins | 115.47 | 1.15 | 3.03 | 103.02 | 8.27 |
| Penicillins | 109.61 | 20.46 | 13.47 | 73.30 | 2.38 |
| Fluoroquinolones | 93.72 | 13.48 | 22.42 | 51.95 | 5.87 |
| Anti-fungal drugs | 92.02 | 0.91 | 13.29 | 68.98 | 8.84 |
| Imidazole derivatives | 27.54 | 4.67 | 4.93 | 16.74 | 1.20 |
| Aminoglycosides | 26.55 | 4.29 | 3.22 | 17.63 | 1.41 |
| Lincosamides | 19.68 | 6.34 | 2.75 | 10.53 | 0.06 |
| Glycylcyclines | 15.67 | 0 | 4.68 | 8.81 | 2.18 |
| Antimycobacterials | 9.74 | 0 | 0 | 0 | 9.74 |
| Oxazolidinones | 8.49 | 0.64 | 0.32 | 7.53 | 0 |
| Sulfonamides | 7.16 | 0 | 4.54 | 2.31 | 0.31 |
| Macrolides | 2.18 | 0.26 | 0 | 1.92 | 0 |
| Aminophenols | 1.52 | 0 | 0 | 1.52 | 0 |
| Tetracyclines | 0.90 | 0 | 0 | 0.90 | 0 |
| Monobactams | 0.43 | 0 | 0 | 0.43 | 0 |
| TOTAL antibacterial treatments | 1080.38 | 153.33 | 171.06 | 687.6 | 68.39 |
| TOTAL antibacterial & anti-fungal treatments | 1172.40 | 154.24 | 184.35 | 756.58 | 77.23 |